华谊腾讯(00419.HK)收购处方药零售平台业务 涉资4亿人民币
华谊腾讯娱乐(00419.HK)公布,透过增资及收购股权,收购处方药新零售平台业务---平潭心伴总股本51%,代价不超过2.04亿人民币;及待目标公司达成首个及第二个表现目标後,公司将收购其余下49%股权,代价不超过1.96亿人民币。
总代价共计4亿人民币,包括现金总额最多1亿人民币;及透过发行代价股支付,首批涉及2,473.2万股,占公司扩大後股本0.18%,发行价0.529元,较上交易日(7日)收报折让2.04%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.